Common Contracts
12 similar Stock Option Agreement contracts by PharmaCyte Biotech, Inc., Nuvilex, Inc.
FOURTH STOCK OPTION AGREEMENTStock Option Agreement • March 13th, 2017 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Fourth Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2017 by and between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
Third STOCK OPTION AGREEMENTStock Option Agreement • March 13th, 2017 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Third Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2017 by and between PharmaCyte Biotech, Inc. (“Company”) and Carlos A. Trujillo (“Participant”).
FOURTH STOCK OPTION AGREEMENTStock Option Agreement • March 13th, 2017 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Fourth Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2017 by and between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).
THIRD STOCK OPTION AGREEMENTStock Option Agreement • March 8th, 2016 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Third Stock Option Agreement (“Agreement”) is made as of the 30th day of December, 2015 by and between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
THIRD STOCK OPTION AGREEMENTStock Option Agreement • March 8th, 2016 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Third Stock Option Agreement (“Agreement”) is made as of the 30th day of December, 2015 by and between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).
FIRST stock option agreementStock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This First Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
FIRST stock option agreementStock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This First Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).
SECOND stock option agreementStock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Second Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Kenneth L. Waggoner (“Participant”).
Second stock option agreementStock Option Agreement • March 13th, 2015 • PharmaCyte Biotech, Inc. • Medicinal chemicals & botanical products • Nevada
This Second Stock Option Agreement (“Agreement”) is made as of the 10th day of March, 2015 (“Effective Date”) between PharmaCyte Biotech, Inc. (“Company”) and Gerald W. Crabtree (“Participant”).
stock option agreementStock Option Agreement • October 3rd, 2014 • Nuvilex, Inc. • Medicinal chemicals & botanical products • New York
This Stock Option Agreement (“Agreement”) is made as of the 29th day of September, 2014 (“Effective Date”) between Nuvilex, Inc. (“Company”) and Richard M. Goldfarb (“Participant”).
stock option agreementStock Option Agreement • October 3rd, 2014 • Nuvilex, Inc. • Medicinal chemicals & botanical products • New York
This Stock Option Agreement (“Agreement”) is made as of the 29th day of September, 2014 (“Effective Date”) between Nuvilex, Inc. (“Company”) and Patricia Gruden (“Participant”).
stock option agreementStock Option Agreement • October 3rd, 2014 • Nuvilex, Inc. • Medicinal chemicals & botanical products • New York
This Stock Option Agreement (“Agreement”) is made as of the 29th day of September, 2014 (“Effective Date”) between Nuvilex, Inc. (“Company”) and Timothy Matula (“Participant”).
